(MRCY) Mercury Systems - Ratings and Ratios
Components, Modules, Subsystems, RF, Processors, Sensors
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 43.7% |
| Value at Risk 5%th | 65.3% |
| Relative Tail Risk | -9.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.46 |
| Alpha | 83.83 |
| CAGR/Max DD | 0.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.493 |
| Beta | 0.733 |
| Beta Downside | 0.425 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.32% |
| Mean DD | 26.05% |
| Median DD | 28.77% |
Description: MRCY Mercury Systems November 09, 2025
Mercury Systems, Inc. (NASDAQ:MRCY) designs, develops, and manufactures high-performance electronic components, modules, and integrated subsystems for defense prime contractors, OEMs, government agencies, and commercial aerospace customers. Its product portfolio spans RF power amplifiers, limiters, switches, oscillators, filters, digital/analog converters, MMICs, memory devices, embedded processing boards, switched-fabric platforms, digital receivers, multi-chip modules, RF/microwave multifunction assemblies, tuners, transceivers, graphics/video solutions, and complete subsystems. The firm also produces digital RF memory units for electronic-warfare, radar-environment simulation and test systems, signals-intelligence payloads, EO/IR technologies for small UAVs, and onboard processors for real-time wide-area motion imagery. Operations are located in the United States, Europe, and the Asia-Pacific.
Key quantitative indicators (FY 2023) include revenue of approximately $1.33 billion, an operating margin near 12 %, and a backlog of roughly $2.5 billion, reflecting strong demand from U.S. defense spending, which is projected to grow at 3-4 % annually through 2028. A material driver for Mercury is the ongoing shift toward software-defined radios and advanced electronic-warfare capabilities, which fuels higher-margin RF-IC and subsystem sales. Additionally, semiconductor supply-chain constraints remain a risk factor; the company’s vertically integrated manufacturing mitigates exposure but could affect lead times if global capacity tightens.
For a deeper quantitative view, you may want to explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-68.4m TTM) > 0 and > 6% of Revenue (6% = 52.3m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 2.59pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 87.53% (prev 79.64%; Δ 7.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 183.5m > Net Income -68.4m (YES >=105%, WARN >=100%) |
| Net Debt (340.4m) to EBITDA (25.6m) ratio: 13.29 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.37 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (59.2m) change vs 12m ago 1.60% (target <= -2.0% for YES) |
| Gross Margin 27.32% (prev 27.59%; Δ -0.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 36.09% (prev 38.24%; Δ -2.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.78 (EBITDA TTM 25.6m / Interest Expense TTM 30.4m) >= 6 (WARN >= 3) |
Altman Z'' 2.29
| (A) 0.31 = (Total Current Assets 1.08b - Total Current Liabilities 322.2m) / Total Assets 2.46b |
| (B) 0.07 = Retained Earnings (Balance) 169.4m / Total Assets 2.46b |
| (C) -0.02 = EBIT TTM -54.1m / Avg Total Assets 2.41b |
| (D) 0.18 = Book Value of Equity 173.6m / Total Liabilities 982.6m |
| Total Rating: 2.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 36.34
| 1. Piotroski 2.50pt |
| 2. FCF Yield 3.77% |
| 3. FCF Margin 18.83% |
| 4. Debt/Equity 0.44 |
| 5. Debt/Ebitda 13.29 |
| 6. ROIC - WACC (= -9.57)% |
| 7. RoE -4.68% |
| 8. Rev. Trend -42.17% |
| 9. EPS Trend -35.02% |
What is the price of MRCY shares?
Over the past week, the price has changed by +7.37%, over one month by +5.31%, over three months by +4.82% and over the past year by +95.50%.
Is MRCY a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 3
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the MRCY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 86 | 15.5% |
| Analysts Target Price | 86 | 15.5% |
| ValueRay Target Price | 86.1 | 15.6% |
MRCY Fundamental Data Overview December 03, 2025
P/E Forward = 106.383
P/S = 4.3039
P/B = 2.8477
P/EG = 2.651
Beta = 0.831
Revenue TTM = 871.0m USD
EBIT TTM = -54.1m USD
EBITDA TTM = 25.6m USD
Long Term Debt = 591.5m USD (from longTermDebt, last quarter)
Short Term Debt = 11.8m USD (from shortTermDebt, two quarters ago)
Debt = 645.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 340.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.36b USD (4.01b + Debt 645.1m - CCE 304.7m)
Interest Coverage Ratio = -1.78 (Ebit TTM -54.1m / Interest Expense TTM 30.4m)
FCF Yield = 3.77% (FCF TTM 164.0m / Enterprise Value 4.36b)
FCF Margin = 18.83% (FCF TTM 164.0m / Revenue TTM 871.0m)
Net Margin = -7.86% (Net Income TTM -68.4m / Revenue TTM 871.0m)
Gross Margin = 27.32% ((Revenue TTM 871.0m - Cost of Revenue TTM 633.1m) / Revenue TTM)
Gross Margin QoQ = 27.93% (prev 27.02%)
Tobins Q-Ratio = 1.77 (Enterprise Value 4.36b / Total Assets 2.46b)
Interest Expense / Debt = 0.91% (Interest Expense 5.86m / Debt 645.1m)
Taxrate = 24.32% (-4.02m / -16.5m)
NOPAT = -40.9m (EBIT -54.1m * (1 - 24.32%)) [loss with tax shield]
Current Ratio = 3.37 (Total Current Assets 1.08b / Total Current Liabilities 322.2m)
Debt / Equity = 0.44 (Debt 645.1m / totalStockholderEquity, last quarter 1.48b)
Debt / EBITDA = 13.29 (Net Debt 340.4m / EBITDA 25.6m)
Debt / FCF = 2.08 (Net Debt 340.4m / FCF TTM 164.0m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.78% (Net Income -68.4m / Total Assets 2.46b)
RoE = -4.68% (Net Income TTM -68.4m / Total Stockholder Equity 1.46b)
RoCE = -2.63% (EBIT -54.1m / Capital Employed (Equity 1.46b + L.T.Debt 591.5m))
RoIC = -1.99% (negative operating profit) (NOPAT -40.9m / Invested Capital 2.06b)
WACC = 7.58% (E(4.01b)/V(4.66b) * Re(8.69%) + D(645.1m)/V(4.66b) * Rd(0.91%) * (1-Tc(0.24)))
Discount Rate = 8.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.30%
[DCF Debug] Terminal Value 67.58% ; FCFE base≈137.1m ; Y1≈90.0m ; Y5≈41.2m
Fair Price DCF = 12.09 (DCF Value 726.7m / Shares Outstanding 60.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -35.02 | EPS CAGR: -10.25% | SUE: 0.57 | # QB: 0
Revenue Correlation: -42.17 | Revenue CAGR: 0.58% | SUE: 0.59 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.22 | Chg30d=-0.024 | Revisions Net=+0 | Analysts=9
EPS current Year (2026-06-30): EPS=1.02 | Chg30d=+0.023 | Revisions Net=+1 | Growth EPS=+58.9% | Growth Revenue=+4.4%
EPS next Year (2027-06-30): EPS=1.57 | Chg30d=+0.024 | Revisions Net=+1 | Growth EPS=+54.9% | Growth Revenue=+8.7%
Additional Sources for MRCY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle